In addition, most contemporary heart failure risk models rely heavily on natriuretic peptides, which were not available in our dataset; therefore, the incremental value of the DNI–CRP axis over natriuretic peptide–based strategies could not be formally quantified in the present study. The gene discussed is CRP; the disease is heart failure.